Four-week pegylated interferon &alpha;-2a monotherapy for chronic hepatitis C with genotype 2 and low viral load: A pilot, randomized study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

204

HTML

1702

Figures (1-1)

157

Tables (1-1)

125

Sum=2188

Dec 21, 2008 (publication date) through May 6, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 21, 2008; 14(47): 7220-7224
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7220

Figure 1 Flow diagram of patients included in the pilot study.

Citation: Tsubota A, Satoh KI, Aizawa M, Takamatsu S, Namiki Y, Ohkusa T, Fujise K, Tajiri H. Four-week pegylated interferon α-2a monotherapy for chronic hepatitis C with genotype 2 and low viral load: A pilot, randomized study. World J Gastroenterol 2008; 14(47): 7220-7224
URL: https://www.wjgnet.com/1007-9327/full/v14/i47/7220.htm
DOI: https://dx.doi.org/10.3748/wjg.14.7220